Cellular and Humoral Mechanisms Involved in the Control of Tuberculosis

被引:108
作者
Zuniga, Joaquin [2 ]
Torres-Garcia, Diana [2 ]
Santos-Mendoza, Teresa [2 ]
Rodriguez-Reyna, Tatiana S. [1 ]
Granados, Julio [3 ]
Yunis, Edmond J. [4 ,5 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City 14000, DF, Mexico
[2] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Lab Immunobiol & Genet, Mexico City 14080, DF, Mexico
[3] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Transplants, Mexico City 14000, DF, Mexico
[4] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA
来源
CLINICAL & DEVELOPMENTAL IMMUNOLOGY | 2012年
关键词
TUMOR-NECROSIS-FACTOR; ADAPTIVE IMMUNE-RESPONSE; IMPAIRED TH1 CYTOKINE; TOLL-LIKE RECEPTORS; LONG-TERM CONTROL; MYCOBACTERIUM-TUBERCULOSIS; RHEUMATOID-ARTHRITIS; T-CELLS; DENDRITIC CELLS; CUTTING EDGE;
D O I
10.1155/2012/193923
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mycobacterium tuberculosis (Mtb) infection is a major international public health problem. One-third of the world's population is thought to have latent tuberculosis, a condition where individuals are infected by the intracellular bacteria without active disease but are at risk for reactivation, if their immune system fails. Here, we discuss the role of nonspecific inflammatory responses mediated by cytokines and chemokines induced by interaction of innate receptors expressed in macrophages and dendritic cells (DCs). We also review current information regarding the importance of several cytokines including IL-17/IL-23 in the development of protective cellular and antibody-mediated protective responses against Mtb and their influence in containment of the infection. Finally, in this paper, emphasis is placed on the mechanisms of failure of Mtb control, including the immune dysregulation induced by the treatment with biological drugs in different autoimmune diseases. Further functional studies, focused on the mechanisms involved in the early host-Mtb interactions and the interplay between host innate and acquired immunity against Mtb, may be helpful to improve the understanding of protective responses in the lung and in the development of novel therapeutic and prophylactic tools in TB.
引用
收藏
页数:18
相关论文
共 206 条
  • [11] CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes
    Andrade, Rosa M.
    Wessendarp, Matthew
    Gubbels, Marc-Jan
    Striepen, Boris
    Subauste, Carlos S.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (09) : 2366 - 2377
  • [12] APPELBERG R, 1994, IMMUNOLOGY, V82, P361
  • [13] PHAGOSOME-LYSOSOME INTERACTIONS IN CULTURED MACROPHAGES INFECTED WITH VIRULENT TUBERCLE-BACILLI - REVERSAL OF USUAL NONFUSION PATTERN AND OBSERVATIONS ON BACTERIAL SURVIVAL
    ARMSTRONG, JA
    HART, PD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1975, 142 (01) : 1 - 16
  • [14] Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
    Askling, J
    Fored, CM
    Brandt, L
    Baecklund, E
    Bertilsson, L
    Cöster, L
    Geborek, P
    Jacobsson, LT
    Lindblad, S
    Lysholm, J
    Rantapää-Dahlqvist, S
    Saxne, T
    Romanus, V
    Klareskog, L
    Feltelius, N
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (07): : 1986 - 1992
  • [15] Bacon K, 2002, J INTERF CYTOK RES, V22, P1067
  • [16] Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis
    Badewa, AP
    Quinton, LJ
    Shellito, JE
    Mason, CM
    [J]. TUBERCULOSIS, 2005, 85 (03) : 185 - 195
  • [17] Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFα
    Baeten, D
    Van Damme, N
    Van den Bosch, F
    Kruithof, E
    De Vos, M
    Mielants, H
    Veys, EM
    De Keyser, F
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (08) : 750 - 755
  • [18] TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis
    Bafica, A
    Scanga, CA
    Feng, CG
    Leifer, C
    Cheever, A
    Sher, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (12) : 1715 - 1724
  • [19] A Novel Human IgA Monoclonal Antibody Protects against Tuberculosis
    Balu, Sucharitha
    Reljic, Rajko
    Lewis, Melanie J.
    Pleass, Richard J.
    McIntosh, Richard
    van Kooten, Cees
    van Egmond, Marjolein
    Challacombe, Stephen
    Woof, Jenny M.
    Ivanyi, Juraj
    [J]. JOURNAL OF IMMUNOLOGY, 2011, 186 (05) : 3113 - 3119
  • [20] HUMORAL RESPONSE TO MYCOBACTERIUM-TUBERCULOSIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    BARRERA, L
    DEKANTOR, I
    RITACCO, V
    RENIERO, A
    LOPEZ, B
    BENETUCCI, J
    BELTRAN, M
    LIBONATTI, O
    PADULA, E
    CASTAGNINO, J
    MONTANER, LG
    [J]. TUBERCLE AND LUNG DISEASE, 1992, 73 (04): : 187 - 191